Kirkland & Ellis acted as legal counsel to Eli Lilly, while for Versanis, Goodwin Procter acted as legal counsel and Cooley advised as to patent matters....
You must be a Standard 1 Year member to access this content.
Goodwin advised Haystack Oncology on the deal. Haystack Oncology announced its definitive agreement to be acquired by Quest Diagnostics (NYSE: DGX). Under the terms of the agreement,...
You must be a Standard 1 Year member to access this content.
Troutman Pepper Hamilton Sanders advised Palvella Therapeutics, Inc. on the deal. Palvella Therapeutics, Inc., a late clinical-stage biopharmaceutical company, announced the initial closing of its Series...
You must be a Standard 1 Year member to access this content.
Troutman Pepper advised Civic Eagle on the deal. Civic Eagle, a technology company providing legislative data and intelligence software solutions, announced its $10 million funding round. The...
You must be a Standard 1 Year member to access this content.
Simpson Thacher represented SK Group on the deal while Troutman Pepper Hamilton Sanders advised Center for Breakthrough Medicines. SK Inc. announced its $350 million investment in The...
You must be a Standard 1 Year member to access this content.
Troutman Pepper Hamilton Sanders advised PharmaCyte Biotech, Inc. on the deal. PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer...
You must be a Standard 1 Year member to access this content.
Troutman Pepper Hamilton Sanders advised PharmaCyte Biotech on the deal. PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and...
You must be a Standard 1 Year member to access this content.
